keyword
https://read.qxmd.com/read/38607246/fgfr1-fusions-as-a-novel-molecular-driver-in-rhabdomyosarcoma
#1
REVIEW
Henry de Traux De Wardin, Joanna Cyrta, Josephine K Dermawan, Delphine Guillemot, Daniel Orbach, Isabelle Aerts, Gaelle Pierron, Cristina R Antonescu
The wide application of RNA sequencing in clinical practice has allowed the discovery of novel fusion genes, which have contributed to a refined molecular classification of rhabdomyosarcoma (RMS). Most fusions in RMS result in aberrant transcription factors, such as PAX3/7::FOXO1 in alveolar RMS (ARMS) and fusions involving VGLL2 or NCOA2 in infantile spindle cell RMS. However, recurrent fusions driving oncogenic kinase activation have not been reported in RMS. Triggered by an index case of an unclassified RMS (overlapping features between ARMS and sclerosing RMS) with a novel FGFR1::ANK1 fusion, we reviewed our molecular files for cases harboring FGFR1-related fusions...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38603649/-nf1-driven-rhabdomyosarcoma-phenotypes-a-comparative-clinical-and-molecular-study-of-nf1-mutant-rhabdomyosarcoma-and-nf1-associated-malignant-triton-tumor
#2
JOURNAL ARTICLE
Henry de Traux de Wardin, Josephine K Dermawan, Fabio Vanoli, Samuel C Jiang, Samuel Singer, Ping Chi, William Tap, Leonard H Wexler, Cristina R Antonescu
PURPOSE: Alterations of the NF1 tumor suppressor gene is the second most frequent genetic event in embryonal rhabdomyosarcoma (ERMS), but its associations with clinicopathologic features, outcome, or coexisting molecular events are not well defined. Additionally, NF1 alterations, mostly in the setting of neurofibromatosis type I (NF1), drive the pathogenesis of most malignant peripheral nerve sheath tumor with divergent RMS differentiation (also known as malignant triton tumor [MTT])...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38597260/tfe3-rearranged-pecoma-pecoma-like-neoplasms-report-of-25-new-cases-expanding-the-clinicopathologic-spectrum-and-highlighting-its-association-with-prior-exposure-to-chemotherapy
#3
JOURNAL ARTICLE
Pedram Argani, John M Gross, Ezra Baraban, Lisa M Rooper, Suping Chen, Ming-Tseh Lin, Christopher Gocke, Abbas Agaimy, Tamara Lotan, Albert J H Suurmeijer, Cristina R Antonescu
Since their original description as a distinctive neoplastic entity, ~50 TFE3-rearranged perivascular epithelioid cell tumors (PEComas) have been reported. We herein report 25 new TFE3-rearranged PEComas and review the published literature to further investigate their clinicopathologic spectrum. Notably, 5 of the 25 cases were associated with a prior history of chemotherapy treatment for cancer. This is in keeping with prior reports, based mainly on small case series, with overall 11% of TFE3-rearranged PEComas being diagnosed postchemotherapy...
April 10, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38517106/spindle-cell-neoplasms-with-novel-ltk-fusion-expanding-the-spectrum-of-kinase-fusion-positive-soft-tissue-tumors
#4
JOURNAL ARTICLE
Maximus C F Yeung, Josephine K Dermawan, Anthony P Y Liu, Albert Y L Lam, Cristina R Antonescu, Tony W H Shek
AIMS: Kinase fusion-positive soft tissue tumors represent an emerging, molecularly defined group of mesenchymal tumors with a wide morphologic spectrum and diverse activating kinases. Here, we present two cases of soft tissue tumors with novel LTK fusions. METHODS AND RESULTS: Both cases presented as acral skin nodules (big toe and middle finger) in pediatric patients (17-year-old girl and 2-year-old boy). The tumors measured 2 and 3 cm in greatest dimension...
March 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38508521/expanding-the-spectrum-of-nr4a3-fusion-positive-gynecologic-leiomyosarcomas
#5
JOURNAL ARTICLE
Amir Momeni-Boroujeni, Kerry Mullaney, Sara E DiNapoli, Mario M Leitao, Martee L Hensley, Nora Katabi, Douglas H R Allison, Kay J Park, Cristina R Antonescu, Sarah Chiang
Recurrent gene fusions have been observed in epithelioid and myxoid variants of uterine leiomyosarcoma. PGR::NR4A3 fusions were recently described in a subset of epithelioid leiomyosarcomas exhibiting rhabdoid morphology. In this study, we sought to expand the clinical, morphologic, immunohistochemical, and genetic features of gynecologic leiomyosarcomas harboring NR4A3 rearrangements with PGR and novel fusion partners. We identified 9 gynecologic leiomyosarcomas harboring PGR::NR4A3, CARMN::NR4A3, ACTB::NR4A3, and possible SLCO5A1::NR4A3 fusions by targeted RNA sequencing...
March 18, 2024: Modern Pathology
https://read.qxmd.com/read/38488807/developing-novel-genomic-risk-stratification-models-in-soft-tissue-and-uterine-leiomyosarcoma
#6
JOURNAL ARTICLE
Josephine K Dermawan, Sarah Chiang, Samuel Singer, Bhumika Jadeja, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Cristina R Antonescu
PURPOSE: Leiomyosarcomas (LMS) are clinically and molecularly heterogeneous tumors. Despite genomic studies, current LMS risk stratification is not informed by molecular alterations. We propose a clinically applicable genomic risk stratification model. EXPERIMENTAL DESIGN: We performed comprehensive genomic profiling in a cohort of 195 soft tissue LMS (STLMS), 151 primary at presentation, and a control group of 238 uterine LMS (ULMS), 177 primary at presentation, with at least one-year follow up...
March 15, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38380774/epithelioid-hemangioendothelioma-ehe-with-wwtr1-tfe3-gene-fusion-a-novel-fusion-variant
#7
JOURNAL ARTICLE
Shuo Li, Josephine K Dermawan, Caleb N Seavey, Shuang Ma, Cristina R Antonescu, Brian P Rubin
Epithelioid hemangioendothelioma (EHE) is a rare endothelial sarcoma associated with a high incidence of metastases and for which there are no standard treatment options. Based on disease-defining mutations, most EHEs are classified into two subtypes: WWTR1::CAMTA1-fused EHE or YAP1::TFE3-fused EHE. However, rare non-canonical fusions have been identified in clinical samples of EHE cases and are challenging to classify. In this study, we report the identification of a novel WWTR1::TFE3 fusion variant in an EHE patient using targeted RNA sequencing...
February 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38335254/chromoplexy-is-a-frequent-early-clonal-event-in-ewsr1-rearranged-round-cell-sarcomas-that-can-be-detected-using-clinically-validated-targeted-sequencing-panels
#8
JOURNAL ARTICLE
Josephine K Dermawan, Emily Slotkin, William D Tap, Paul Meyers, Leonard Wexler, John Healey, Fabio Vanoli, Chad M Vanderbilt, Cristina R Antonescu
Chromoplexy is a phenomenon defined by large-scale chromosomal chained rearrangements. A previous study observed chromoplectic events in a subset of Ewing sarcomas (ES), which was linked to an increased relapse rate. Chromoplexy analysis could potentially facilitate patient risk stratification, particularly if it could be detected with clinically applied targeted next-generation sequencing (NGS) panels. Using DELLY, a structural variant (SV) calling algorithm that is part of the MSK-IMPACT pipeline, we characterized the spectrum of SVs in EWSR1-fused round cell sarcomas, including 173 ES and 104 desmoplastic small round cell tumors (DSRCT), to detect chromoplexy and evaluate its association with clinical and genomic features...
February 9, 2024: Cancer Research
https://read.qxmd.com/read/38276052/chorea-and-cognitive-impairment-in-jak2v617f-positive-myeloproliferative-disorders-a-case-report-and-literature-review
#9
REVIEW
Ioana Butnariu, Dana Antonescu-Ghelmez, Adriana Moraru, Daniela Nicoleta Anghel, Florentina Melania Cojocaru, Sorin Tuță, Adela Magdalena Ciobanu, Florian Antonescu
Chorea is a hyperkinetic movement disorder, accompanied by dystonia, myoclonus, tics, stereotypies, and tremors. It is characterized by excessive, purposeless movements that are distressing, irregularly timed, and randomly distributed. Chorea can be present in many diseases, such as hereditary, metabolic disturbance, drug-induced, and functional disorders, and, rarely, genetic, autoimmune, and infectious diseases. Primary myelofibrosis (PMF) is a myeloproliferative neoplasm that leads to ineffective clonal hematopoiesis, fibrous tissue deposits in the bone marrow, extramedullary hematopoiesis, and splenomegaly...
December 21, 2023: Medicina
https://read.qxmd.com/read/38275898/cic-dux4-chromatin-profiling-reveals-new-epigenetic-dependencies-and-actionable-therapeutic-targets-in-cic-rearranged-sarcomas
#10
JOURNAL ARTICLE
Arnaud Bakaric, Luisa Cironi, Viviane Praz, Rajendran Sanalkumar, Liliane C Broye, Kerria Favre-Bulle, Igor Letovanec, Antonia Digklia, Raffaele Renella, Ivan Stamenkovic, Christopher J Ott, Takuro Nakamura, Cristina R Antonescu, Miguel N Rivera, Nicolò Riggi
CIC-DUX4-rearranged sarcoma (CDS) is a rare and aggressive soft tissue tumor that occurs most frequently in young adults. The key oncogenic driver of this disease is the expression of the CIC-DUX4 fusion protein as a result of chromosomal rearrangements. CIC-DUX4 displays chromatin binding properties, and is therefore believed to function as an aberrant transcription factor. However, the chromatin remodeling events induced by CIC-DUX4 are not well understood, limiting our ability to identify new mechanism-based therapeutic strategies for these patients...
January 21, 2024: Cancers
https://read.qxmd.com/read/38189436/vascular-neoplasms-with-nfatc1-c2-gene-alterations-expanding-the-clinicopathologic-and-molecular-characteristics-of-a-distinct-entity
#11
JOURNAL ARTICLE
Nooshin K Dashti, Raul Perret, Bonnie Balzer, Rana Naous, Michael Michal, Josephine K Dermawan, Cristina R Antonescu
Despite significant advances in their molecular pathogenesis, skeletal vascular tumors remain diagnostically challenging due to their aggressive radiologic appearance and significant morphologic overlap. Within the epithelioid category and at the benign end of the spectrum, recurrent FOS/FOSB fusions have defined most epithelioid hemangiomas, distinguishing them from epithelioid hemangioendothelioma and angiosarcoma. More recently, the presence of EWSR1/FUS :: NFATC1/2 fusions emerged as the genetic hallmark of a novel group of unusual vascular proliferations, often displaying epithelioid morphology, with alternating vasoformative and solid growth, variable atypia, reminiscent of composite hemangioendothelioma...
April 1, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38163103/velocity-changes-in-femoral-vessel-ultrasound-with-doppler-in-porcine-hemorrhagic-shock
#12
JOURNAL ARTICLE
Ioana Antonescu, Brad Moore, Erica Peethumnongsin, Sean P Montgomery
OBJECTIVE: Physician-directed point-of-care ultrasound (PoCUS) is routinely used to identify the etiology of shock and guide therapy in the ICU. We performed a preclinical study to determine what changes are manifested in the femoral vessels during hemorrhagic shock on Duplex imaging and to generate a femoral vessel sonographic profile over the time course of shock. DESIGN & SETTING: A preclinical study in swine was performed using a convenience sample of animals that were being used in a Trauma Surgery training lab...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38141829/sarcomas-with-rad51b-fusions-are-associated-with-a-heterogeneous-phenotype
#13
JOURNAL ARTICLE
Hsin-Yi Chang, Josephine Dermawan, Aarti Sharma, Brendan Dickson, Gulisa Turashvili, Dianne Torrence, Marisa Nucci, Sarah Chiang, Esther Oliva, Martina Kirchner, Albrecht Stenzinger, Gunhild Mechtersheimer, Cristina Antonescu
RAD51B-rearranged sarcomas are rare neoplasms that exhibit a heterogeneous morphology. To date, 6 cases have been reported, all involving the uterus, including 4 perivascular epithelioid cell tumors (PEComas) and 2 leiomyosarcomas (LMS). In this study, we describe the morphologic, immunohistochemical, and molecular features of 8 additional sarcomas with RAD51B rearrangement, including the first extrauterine example. All patients were women with a median age of 57 years at presentation. Seven tumors originated in the uterus, and one in the lower extremity soft tissue, with a median tumor size of 12 cm...
February 2024: Modern Pathology
https://read.qxmd.com/read/38138266/neuro-beh%C3%A3-et-s-disease-onset-in-the-context-of-tuberculous-meningoencephalitis-a-case-report
#14
Florian Antonescu, Ioana Butnariu, Dana Antonescu-Ghelmez, Sorin Tuta, Bianca Adriana Voinescu, Mihnea Costin Manea, Amanda Ioana Bucur, Altay Sercan Chelmambet, Adriana Moraru
Behçet's disease (BD) is a systemic vasculitis that frequently presents with a relapsing-remitting pattern. CNS involvement (Neuro-Behçet) is rare, affecting approximately 10% of patients. Its etiological mechanisms are not yet fully understood. The most commonly accepted hypothesis is that of a systemic inflammatory reaction triggered by an infectious agent or by an autoantigen, such as heat shock protein, in genetically predisposed individuals. Mycobacterium tuberculosis is known to be closely interconnected with BD, both affecting cell-mediated immunity to a certain extent and probably sharing a common genetic background...
December 13, 2023: Medicina
https://read.qxmd.com/read/38050902/expanding-the-molecular-landscape-of-undifferentiated-sarcomas-of-bone-with-a-novel-ewsr1-ssx3-gene-fusion
#15
JOURNAL ARTICLE
Caterina Fumagalli, Ruth Orellana, Malena Ferré, Allan Gonzalez, Lluis Catasús, Tania Vázquez, Ana Sebio, Antonio López-Pousa, Jaume Llauger, Ana Peiró, Cristina R Antonescu
Undifferentiated sarcomas characterized by a primitive monomorphic round to spindle cell phenotype and often non-specific immunoprofile remain difficult to subclassify outside molecular analysis. The increased application of RNA sequencing in clinical practice led to significant advances and discoveries of novel gene fusions that furthered our understanding and refined classification of otherwise undifferentiated neoplasms. In this study, we report an undifferentiated round to spindle cell sarcoma arising in the femur of a 34-year-old female...
January 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/37947157/a-phase-2-study-of-mk-2206-in-patients-with-incurable-adenoid-cystic-carcinoma-alliance-a091104
#16
JOURNAL ARTICLE
Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R Antonescu, Gary P Frenette, David G Pfister, Charles Erlichman, Gary K Schwartz
BACKGROUND: Recurrent/metastatic adenoid cystic carcinoma (ACC) is a rare, incurable disease. MYB is a putative oncogenic driver in ACC that is often overexpressed through an MYB-NFIB rearrangement. The authors hypothesized that AKT inhibition with the allosteric inhibitor MK-2206 could decrease MYB expression and induce tumor regression in patients with incurable ACC (ClinicalTrials.gov identifier NCT01604772). METHODS: Patients with progressive, incurable ACC were enrolled and received MK-2206 150 mg weekly; escalation to 200 mg was allowed...
November 10, 2023: Cancer
https://read.qxmd.com/read/37916971/translational-aspects-of-epithelioid-sarcoma-current-consensus
#17
JOURNAL ARTICLE
Thomas G P Grünewald, Sophie Postel-Vinay, Robert T Nakayama, Noah E Berlow, Andrea Bolzicco, Vincenzo Cerullo, Josephine K Dermawan, Anna Maria Frezza, Antoine Italiano, Jia Xiang Jin, François Le Loarer, Javier Martín-Broto, Andrew Pecora, Antonio Perez-Martinez, Yuen Bun Tam, Franck Tirode, Annalisa Trama, Sandro Pasquali, Mariagrazia Vescia, Lukas Wortmann, Michael Wortmann, Akihiko Yoshida, Kim Webb, Paul H Huang, Charles Keller, Cristina R Antonescu
Epithelioid sarcoma (EpS) is an ultra-rare malignant soft-tissue cancer mostly affecting adolescents and young adults. EpS often exhibits an unfavorable clinical course with fatal outcome in ~50% of cases despite aggressive multimodal therapies combining surgery, chemotherapy, and irradiation. EpS is traditionally classified in a more common, less aggressive distal (classic) type, and a rarer aggressive proximal type. Both subtypes are characterized by a loss of nuclear INI1 expression, most often following homozygous deletion of its encoding gene SMARCB1 - a core subunit of the SWI/SNF chromatin remodeling complex...
November 2, 2023: Clinical Cancer Research
https://read.qxmd.com/read/37900104/doxycycline-inducible-expression-of-proteins-at-near-endogenous-levels-in-mammalian-cells-using-the-sleeping-beauty-transposon-system
#18
JOURNAL ARTICLE
Karolina Zak, Costin N Antonescu
The function of a protein within a cell critically depends on its interaction with other proteins as well as its subcellular localization. The expression of mutants of a particular protein that have selective perturbation of specific protein interaction motifs is a very useful strategy for resolving a protein's mechanism of action in a cellular process. In addition, expression of fluorescent protein fusions is a key strategy for determining the subcellular localization of a protein. These strategies require tight regulation to avoid potential alterations in protein interactions or localizations that can result from protein overexpression...
October 20, 2023: Bio-protocol
https://read.qxmd.com/read/37819540/when-molecular-outsmarts-morphology-malignant-ossifying-fibromyxoid-tumors-masquerading-as-osteosarcomas-including-a-novel-crebzf-phf1-fusion
#19
JOURNAL ARTICLE
Aarti E Sharma, Josephine K Dermawan, Andy E Sherrod, Shefali Chopra, Robert G Maki, Cristina R Antonescu
We present two cases of malignant ossifying fibromyxoid tumor (OFMT) which eluded diagnosis due to compelling clinicopathologic mimicry, compounded by similarly elusive underlying molecular drivers. The first is of a clavicle mass in a 69 year-old female, which histologically showed an infiltrative nested and trabeculated proliferation of monomorphic cells giving rise to scattered spicules of immature woven bone. Excepting SATB2 positivity, the lesion showed an inconclusive immunoprofile which along with negative PHF1 FISH led to an initial diagnosis of high-grade osteosarcoma...
January 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/37782551/kinase-fusion-positive-intra-osseous-spindle-cell-tumors-a-series-of-eight-cases-with-review-of-the-literature
#20
REVIEW
Albert J H Suurmeijer, Bin Xu, Dianne Torrence, Brendan C Dickson, Cristina R Antonescu
Mesenchymal spindle cell tumors with kinase fusions, often presenting in superficial or deep soft tissue locations, may rarely occur in bone. Herein, we describe the clinicopathologic and molecular data of eight bone tumors characterized by various kinase fusions from our files and incorporate the findings with the previously reported seven cases, mainly as single case reports. In the current series all but one of the patients were young children or teenagers, with an age range from newborn to 59 years (mean 19 years)...
January 2024: Genes, Chromosomes & Cancer
keyword
keyword
48925
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.